+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of HTLV-1 associated adult T-cell leukemia lymphoma with a combination of Zidovudine and alpha interferon Report of the French experience



Treatment of HTLV-1 associated adult T-cell leukemia lymphoma with a combination of Zidovudine and alpha interferon Report of the French experience



Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 20(4): A7, April 4




(PDF emailed within 1 workday: $29.90)

Accession: 035980471

Download citation: RISBibTeXText


Related references

Treatment of HTLV-I associated adult T-cell leukemia-lymphoma with a combination of zidovudine and interferon-alpha. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 10(2): 284, 1995

Treatment of HTLV-1 associated adult T-cell leukemia-lymphoma with a combination of zidovudine and interferon-alpha. Blood 86(10 SUPPL 1): 931A, 1995

Treatment of HTLV-1 associated adult T-cell leukemia lymphoma with a combination of Zidovudine and alpha interferon. Blood 90(10 SUPPL 1 PART 1): 332A-333A, Nov 15, 1997

The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma. Leukemia & Lymphoma 40(3-4): 287-294, 2001

Treatment of HTLV-I associated adult T-cell leukemia/lymphoma with a combination of interferon-alpha and AZT. AIDS Research & Human Retroviruses 10(SUPPL 1): S116, 1994

Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 13 Suppl 1: S186-S190, 1996

Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma. Leukemia 14(4): 716-721, 2000

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. New England Journal of Medicine 332(26): 1744-1748, 1995

The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma. Retrovirology 10(): 91-91, 2014

Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. New England Journal of Medicine 332(26): 1749-1751, 1995

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL). Blood 113(26): 6528-6532, 2009

Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran. Leukemia & Lymphoma 48(2): 330-336, 2007

Unsuccessful association of zidovudine and interferon alpha for acute adult T-cell leukemia lymphoma. Dermatology 198(1): 103-105, 1999

Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha. Leukemia & Lymphoma 51(7): 1200-1216, 2010

An adolescent with HTLV-I-associated adult T cell leukemia treated with interferon-alfa and zidovudine. Leukemia 10(7): 1244-1248, 1996